Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Phase 3
×
Breast Neoplasms
×
capivasertib
×
Clear all
Filters
3
NCT06982521
2026-03-03
ReDiscover-2
Relay Therapeutics, Inc.
Phase 3
Recruiting
540 enrolled
NCT07281833
2026-02-27
CAPIcorn
West German Study Group
Phase 3
Recruiting
250 enrolled
NCT06635447
2026-01-13
CAPItrue
AstraZeneca
Phase 3
Recruiting
300 enrolled
NCT06764186
2026-01-13
CAPItana
AstraZeneca
Phase 3
Active not recruiting
101 enrolled
NCT03997123
2025-12-22
CAPItello-290
AstraZeneca
Phase 3
Active not recruiting
923 enrolled